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Introduction
Epidemiological studies have demonstrated 
an association between exposure to ambient 
particulate matter (PM) at concentrations 
currently found in major metropolitan areas 
and a broad range of adverse cardiovascular 
outcomes (U.S. EPA 2009). A recent scien-
tific statement from the American Heart 
Association concluded that short-term 
elevations in PM concentrations are capable 
of triggering acute coronary syndrome and 
stroke, worsening heart failure, and provoking 
arrhythmias among individuals  with 
pre existing heart disease (Brook et al. 2010).
Ambient PM is a complex and variable 
mixture of particles of varying size that are 
classified into coarse (PM2.5–10; from 2.5 μm 
to 10 μm in aerodynamic diameter), fine 
(PM2.5; < 2.5 μm), and ultrafine (PM0.1; 
< 0.1 μm) particles. In the present study, 
research volunteers were exposed to PM2.5 
particles concentrated from the air (CAP) 
in Chapel Hill, North Carolina. Short-
term controlled human exposure to PM2.5 
increases blood pressure (BP) and impairs 
endothelial function (Brook et al. 2009) in 
young healthy adults. Controlled exposure 
to diesel exhaust, a component of ambient 
PM, has been shown to affect fibrino-
lysis (Mills et al. 2005). A recent epide-
miological study has associated long-term 
exposure to PM with decreased endothelial 
function (Krishnan et al. 2012). Moreover, 
PM2.5 exposure in the Chapel Hill airshed 
was associated with immediate endothelial 
dysfunction in diabetic patients (Schneider 
et al. 2008). In addition, several controlled 
human exposure studies have suggested that 
air pollution exposure increases BP during 
(Brook et al. 2009; Urch et al. 2005) and 
immediately after (Mills et al. 2005) PM 
exposure, and ambient PM2.5 levels have been 
associated with higher BP in epidemiological 
studies (Auchincloss et al. 2008). However, 
the mechanisms of these vascular effects asso-
ciated with exposure to ambient PM are still 
not well understood.
Endothelial dysfunction is a critical early 
event in the development of athero sclerosis 
(Ross 1993). Endothelial dysfunction is 
defined as an imbalance between vasodilating 
and vaso constricting substances produced by 
and acting on the endothelium. Endothelial 
dysfunction results in elevated expression of 
chemokines, cytokines, and adhesion mole-
cules that promote smooth muscle cell growth, 
platelet and leukocyte adhesion, thrombosis, 
and vascular inflammation. Endothelial 
dysfunction induced by air pollution exposure 
has been implicated as an important mecha-
nism in the development of cardio vascular 
diseases (Brook et al. 2010; Krishnan et al. 
2013). Inflammation and oxidative stress 
mediate the adverse cardio vascular effects of 
air pollution exposure (Brook et al. 2010). 
Dietary supplements such as olive oil (OO) 
and fish oil (FO) have been shown to have 
anti oxidant and anti-inflammatory effects 
(Moreno and Mitjavila 2003) that might 
offer protection against air pollution exposure. 
Consumption of OO, a principal component 
of the Mediterranean diet, has been shown 
to improve endothelial function and blood 
lipid profile (Zern and Fernandez 2005), 
decrease platelet aggregation (Delgado-Lista 
Address correspondence to H. Tong, Environmental 
Pub l i c  Hea l th  Div i s ion ,  NHEERL,  U.S . 
Environmental Protection Agency, 109 T.W. 
Alexander Dr., Research Triangle Park, NC 27709 
USA. Telephone: (919) 966-4993. E-mail: tong.
haiyan@epa.gov
Supplemental Material is available online (http://
dx.doi.org/10.1289/ehp.1408988).
We thank J. Carter, M. Schmitt, and J. Wood for 
their excellent clinical and technical assistance in the 
execution of this study. We thank Pharmavite LLC 
(Mission Hills, CA) for providing the fish oil and 
olive oil supplements used in this study. 
The U.S. Environmental Protection Agency 
Intramural Research Program supported this 
research. This project is supported in part by 
National Institutes of Health grant RR00046 to 
the UNC-Chapel Hill Clinical and Translational 
Research Center. J.H.B. is employed by TRC 
Environmental Corporation. 
The research described in this article has been 
reviewed by the National Health and Environmental 
Effects Research Laboratory, U.S. EPA, and approved 
for publication. The contents of this article should 
not be construed to represent agency policy nor does 
mention of trade names or commercial products 
constitute endorsement or recommendation for use.
The authors declare they have no actual or potential 
competing financial interests.
Received: 23 July 2014; Accepted: 28 April 2015; 
Advance Publication: 1 May 2015; Final Publication: 
1 November 2015.
Dietary Supplementation with Olive Oil or Fish Oil and Vascular Effects of 
Concentrated Ambient Particulate Matter Exposure in Human Volunteers
Haiyan Tong,1 Ana G. Rappold,1 Melissa Caughey,2 Alan L. Hinderliter,2 Maryann Bassett,1 Tracey Montilla,1 
Martin W. Case,1 Jon Berntsen,3 Philip A. Bromberg,2 Wayne E. Cascio,1 David Diaz-Sanchez,1 Robert B. Devlin,1 
and James M. Samet1
1Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection 
Agency, Research Triangle Park, North Carolina, USA; 2Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, 
North Carolina, USA; 3TRC Environmental Corporation, Raleigh, North Carolina, USA
Background: Exposure to ambient particulate matter (PM) induces endothelial dysfunction, a 
risk factor for cardiovascular disease. Olive oil (OO) and fish oil (FO) supplements have beneficial 
effects on endothelial function.
oBjective: In this study we evaluated the potential efficacy of OO and FO in mitigating endothelial 
dysfunction and disruption of hemostasis caused by exposure to particulate matter (PM).
Methods and results: Forty-two participants (58 ± 1 years of age) received either 3 g/day of OO 
or FO, or no supplements (naive) for 4 weeks prior to undergoing 2-hr exposures to filtered air 
and concentrated ambient particulate matter (CAP; mean, 253 ± 16 μg/m3). Endothelial function 
was assessed by flow-mediated dilation (FMD) of the brachial artery preexposure, immediately 
post exposure, and 20 hr post exposure. Levels of endothelin-1 and markers of fibrinolysis and 
inflammation were also measured. The FMD was significantly lower after CAP exposure in the 
naive (–19.4%; 95% CI: –36.4, –2.3 per 100 μg/m3 CAP relative to baseline; p = 0.03) and FO 
groups (–13.7%; 95% CI: –24.5, –2.9; p = 0.01), but not in the OO group (–7.6%; 95% CI: 
–21.5, 6.3; p = 0.27). Tissue plasminogen activator levels were significantly increased immedi-
ately after (11.6%; 95% CI: 0.8, 22.2; p = 0.04) and 20 hr after CAP exposure in the OO group. 
Endothelin-1 levels were significantly increased 20 hr after CAP exposure in the naive group only 
(17.1%; 95% CI: 2.2, 32.0; p = 0.03).
conclusions: Short-term exposure to CAP induced vascular endothelial dysfunction. OO 
supplementation attenuated CAP-induced reduction of FMD and changes in blood markers 
associated with vasoconstriction and fibrinolysis, suggesting that OO supplementation may be an 
efficacious intervention to protect against vascular effects of exposure to PM.
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et al. 2011), and reduce vascular inflammation 
(Esposito et al. 2004). In particular, some 
components of OO, such as poly phenols 
(Moreno-Luna et al. 2012; Zern and 
Fernandez 2005) and oleic acid (Perona et al. 
2006), have been shown to have beneficial 
effects on endothelial function. Therefore, 
OO supplementation is a potential candidate 
for use as a protective intervention against 
the adverse vascular effects of PM exposure. 
Dietary supplementation with FO has been 
shown to improve endothelial function in 
patients who smoke tobacco or who have 
elevated insulin, glucose, or triglyceride levels 
(Duda et al. 2009a; Saravanan et al. 2010). 
However, the effects of OO and FO on 
vascular responses to air pollution exposure 
have not been examined specifically.
In the present study, we assessed the acute 
effects of controlled exposure to ambient air 
PM2.5 on vascular endothelial function, blood 
pressure, and fibrinolysis and inflammation in 
healthy middle-aged human volunteers, and 
evaluated the efficacy of a 4-week regimen of 
dietary supplementation with OO or FO as a 
means to mitigate vascular effects induced by 
PM exposure.
Methods
Study participants. Forty-two participants 
ranging in age from 50 to 72 years (mean 
58 ± 1 years) were enrolled in the study. None 
had a history of heart disease, uncontrolled 
hypertension, pulmonary disease, diabetes 
mellitus, hypercholesterolemia, or active 
allergy, and none had smoked for the past year. 
Participants were not taking n-3 or n-9 fatty 
acid (FA) supplements, anti-inflammatory 
drugs [e.g., nonsteroidal anti-inflammatory 
drugs (NSAIDs)], or anti oxidant supplements 
(e.g., beta-carotene, selenium, vitamin C, and 
vitamin E). All participants were instructed 
to avoid food sources of n-3 and n-9 FA for 
6 weeks and refrain from using any NSAIDs 
for 2 weeks prior to each exposure. They 
were also asked to abstain from alcohol 
and caffeine and adhere to a low-fat diet 
for 24 hr before exposures. The Biomedical 
Institutional Review Board at the University 
of North Carolina at Chapel Hill and the U.S. 
Environmental Protection Agency approved 
the study protocol, recruitment materials, and 
consent forms. All study participants gave 
informed consent and received monetary 
compensation for their participation.
Study design .  Al l  exposures  were 
conducted in the U.S. Environmental 
Protection Agency Human Studies Facility 
(HSF) on the medical campus of the 
University of North Carolina at Chapel Hill 
as described previously (Tong et al. 2012). At 
the end of 28 days of dietary supplementation, 
each participant was exposed first to filtered 
air and then returned to the HSF the next 
morning to undergo exposure to CAP. The 
participants were blinded to the exposure. The 
exposures were conducted at the same time of 
the day and on the same 2 days of the week. 
Participants were exposed for 2 hr through a 
face mask in an exposure chamber in which 
temperature and humidity were controlled. 
They remained at rest in a seated position 
throughout the exposure.
The following procedures were performed 
on each participant beginning at approxi-
mately 0800 hours (2 hr before chamber 
exposure to filtered air): Venous blood was 
collected, BP was recorded, and the diameter 
and flow-mediated dilation (FMD) of the 
brachial artery were measured by ultrasound. 
The same procedures were repeated imme-
diately after the 2-hr filtered-air exposure 
(Post) and again the next morning at approxi-
mately 0800 hours (Follow-up). These latter 
measurements also served as the preexposure 
values for the CAP exposure. At approxi-
mately 1000 hours on the second day, partici-
pants were exposed to CAP for 2 hr. As with 
the filtered-air exposure, post and follow-up 
measurements were obtained immediately 
after CAP exposure and beginning at 0800 
hours the next morning.
Dietary supplementation. As described 
previously (Tong et al. 2012), all participants 
were asked to restrict their intake of foods 
containing n-3 and n-9 FA for the 2-week 
period prior to and during the 4-week dietary 
supplementation period. Thirteen participants 
received 3 g/day (three 1-g capsules daily) 
of OO, 16 participants received 3 g/day 
(three 1-g capsules daily) of marine-derived 
n-3 FA (FO), and 13 participants were not 
supplemented (naive) for 28 days prior to 
the filtered-air exposure day. The partici-
pants were supplemented with OO or FO 
up to and including the days of exposure. 
FO and OO assignments were made using 
a randomized, double-blinded study design. 
Participants were also asked to keep 3-day 
food records during the second and fourth 
weeks of the supplementation period to assess 
compliance with the dietary restrictions. 
Nutrition Data System for Research software 
(NDSR; University of Minnesota) was used 
to analyze the food records and estimate 
intakes of nutrients that may confound n-3 
FA. Each 1-g OO capsule contained < 1% of 
n-3 FA, with 73% of the FA content being 
oleic acid and 12% palmitic acid. Each 1-g 
FO capsule contained approximately 65% 
n-3 FA, consisting of 410 mg EPA (eicosa-
pentaenoic acid) and 274 mg of DHA (doco-
sahexaenoic acid). Pharmavite LLC kindly 
provided the OO and FO supplements. All 
capsules used in this study were derived from 
single lots. The ratios of the major plasma FAs 
were measured at the end of the supplementa-
tion period to determine whether ratios were 
consistent with expectations for the FO and 
OO groups, and the data has been reported 
previously (Tong et al. 2012).
Controlled exposure. CAP was generated 
as described previously (Tong et al. 2012) 
by drawing ambient air from above the roof 
of the HSF in Chapel Hill, North Carolina, 
and passing it through a two-stage aerosol 
concentrator capable of producing up to a 
30-fold increase in particle number and 
mass. Air temperature and humidity were 
controlled inside the chamber. The concen-
tration of particles delivered to the chamber 
varied with the level of naturally occurring 
ambient particles in the Chapel Hill airshed 
at the time of the exposure. Particle mass and 
number concentrations at the chamber inlet 
were monitored continuously as described 
previously (Samet et al. 2009). A particle 
dilution system was used to limit the maximal 
particle concentration and prevent it from 
exceeding 600 μg/m3 for > 6 min at any time 
during exposure. A face mask was used to 
assure concordance between the PM concen-
tration in the chamber and the concentration 
actually inhaled by the participant. Teflon 
filter samples were also obtained and analyzed 
for particle mass gravimetrically.
The 2-hr average fine/ultrafine CAP 
mass concentration in the chamber was 
253 ± 16 μg/m3 (mean ± SE). The PM2.5 
concentration and particle number during 
the 2-hr CAP exposure, as well as particle 
size, is reported in Supplemental Material, 
Table S1 and Figure S1. An estimated 75% 
of particles were in the ultrafine range during 
exposure. The maximum 2-hr average inhala-
tion exposure in this study is comparable to 
approximately 24-hr exposure to PM2.5 at the 
current 24-hr National Ambient Air Quality 
Standard (NAAQS) (U.S. EPA 2012). No 
clinically significant events associated with 
CAP exposure were observed in any of the 
study participants.
Brachial artery ultrasound. As described 
previously (Guthikonda et al. 2007; Schneider 
et al. 2008), FMD was measured by brachial 
artery ultrasound in the University of North 
Carolina Hospitals Clinical Translational 
Research Center (CTRC) using a 12.5-MHz 
imaging probe interfaced with an ATL 
HDI 5000 ultrasound machine (Philips), or 
on-site at the U.S. Environmental Protection 
Agency HSF using a 15-MHz imaging probe 
interfaced with an Acuson Sequoia 512 
ultrasound machine (Siemens). The partici-
pants were transported from the HSF to 
the UNC-CTRC by an E85-fueled vehicle. 
Baseline images of the right brachial artery 
were captured at end diastole. The FMD was 
assessed after reactive hyperemia induced 
by inflating a pneumatic tourniquet applied 
distal to the antecubital fossa to a supra systolic 
pressure for 5 min (Guthikonda et al. 2007). 
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Hyperemic images were captured for 90 sec 
following cuff deflation. Brachial arterial 
diameter (BAD) was measured at baseline 
and at maximum dilation with customized 
software that utilizes edge-detection tech-
nology (Vascular Research Tools, version 
5.9.0; Medical Imaging Applications). 
BP measurements. BP was measured 
using a validated ambulatory BP monitor 
(Oscar-2; SunTech Medical) at 15-min inter-
vals during 2 hr of exposure and at 30-min 
intervals before and after filtered-air and CAP 
exposure. A single reading at each time point 
was acquired and used in the analysis.
Measurement of endothelin‑1 and 
markers of fibrinolysis and inflammation. 
Venous blood was obtained 2 hr before, 
immediately after, and 20 hr after each 
exposure. Anticoagulated plasma samples 
were stored at –80°C until assayed in our 
laboratory using commercially available 
ELISA kits to quantify levels of fibrinolysis 
markers including tissue-type plasminogen 
activator (tPA) and plasminogen (Enzyme 
Research Laboratories); D-dimer and von 
Willebrand factor (vWF) (Diagnostisca 
Stago); plasminogen activator inhibitor-1 
(PAI-1) (DakoCytomation); inflammatory 
markers including fibrinogen (Diasorin), 
interleukin (IL)-6, IL-8, tumor necrosis factor 
alpha (TNFα), and C-reactive protein (CRP) 
(Meso Scale Discovery); vascular inflamma-
tory markers including vascular cell adhesion 
molecule 1 (VCAM-1) and intercellular 
adhesion molecule 1 (ICAM-1) (Meso Scale 
Discovery); and vasoconstrictor endothelin-1 
(Bachem Group). 
Statistical analysis. To evaluate changes 
between CAP and filtered-air exposures 
within participants, as well as differences 
between the OO, FO, and naive groups, 
we used a two-factor (supplement and CAP 
concentration) mixed-effects model with 
a participant-specific random intercept. 
Changes within individuals were evalu-
ated at two time points separately: imme-
diately after and approximately 20 hr after 
exposure to CAP and filtered air, denoted 
“Post” and “Follow-up,” respectively. Prior 
to the analysis, we normalized all Post and 
Follow-up outcomes to their preexposure 
baseline (Post/Pre, Follow-up/Pre) to control 
for day-to-day variability. The exposure 
variable PM was treated as continuous, 
and changes between CAP and filtered-air 
exposures were expressed as percent point 
differences per 100-μg/m3 increase in CAP 
concentration relative to baseline, with the 
associated 95% confidence interval (CI). 
To test differences in baselines between the 
three groups and differences between expo-
sures we used a two-factor mixed-effects 
model [exposure = (before filtered air, 
before CAPs), group = (OO, FO, naive)]. 
There were more females than males in each 
dietary supplement group in this study, 
and the ratio of females to males varied 
(9:4, 12:4, and 11:2 in OO, FO, and naive 
groups, respectively). However, the great 
majority of female participants (29 of 32) 
were post menopausal, and only 4 were on 
hormone replacement therapy (Table 1). To 
examine the influence of sex on responses 
to CAP and the outcomes, we conducted 
sensitivity analyses for selected end points 
by adjusting for sex as a confounder and by 
restricting analyses to women only. We did 
not have sufficient power to evaluate effect 
modification of associations with CAP, or of 
differences according to supplement group, 
by sex. We also examined the sensitivity of 
results with respect to medication usage by 
excluding 5 participants taking statins or ACE 
(angiotensin-converting enzyme) inhibitors. 
R statistical software (version 2.15.0; R Core 
Team 2012) was used for analysis, and a 
p-value < 0.05 was considered significant.
Results
Table 1 presents characteristics of the 
research participants. Age, body mass index 
(BMI), smoking history, medication usage, 
BP, serum glucose, and lipids did not differ 
statistically among the groups. Before starting 
supplementation with OO or FO, or no 
supplements (naive), all participants reported 
low dietary intakes of foods rich in n-3 and 
n-9 FA (Tong et al. 2012). Participants 
showed good compliance with their adher-
ence to the dietary restriction and OO or FO 
supplementation schedule (Tong et al. 2012).
Endothelial function .  The average 
baseline diameter and FMD of brachial 
artery measured before, immediately after, 
and 20 hr after CAP exposure are presented 
in Supplemental Material ,  Table S2. 
Compared with the naive group, the mean 
value of FMD measured prior to the filtered-
air exposure was higher in the FO group 
(7.19 ± 0.88 vs. 6.57 ± 0.65; p = 0.08) when 
analyzed using a two-factor mixed-effects 
linear model for differences in baselines 
between exposures (filtered air, CAP) and 
supplemental groups (OO, FO, naive). There 
were no significant differences among the pre-
filtered air–exposure diameter mean values in 
the OO, FO, and naive groups.
The mean percent difference in FMD 
and baseline BAD per 100-μg/m3 increase 
in CAP concentration immediately after 
and 20 hr after CAP exposure relative 
to filtered-air control is shown in Table 2. 
Table 1. Characteristics of the participants before dietary restriction and supplementation.
Characteristic Olive oil (n = 13) Fish oil (n = 16) Naive (n = 13)
Sex (male/female; n) 4/9 4/12 2/11
Age (years) 59.3 ± 1.1 57.4 ± 1.4 57.8 ± 1.3
Post menopausal (n) 8 11 10
Race (white/black; n) 11/2 10/6 10/3
BMI (kg/m2) 26.3 ± 1.3 27.6 ± 1.1 24.9 ± 1.2
Systolic blood pressure (mmHg) 123 ± 3 122 ± 3 121 ± 2
Diastolic blood pressure (mmHg) 77 ± 2 77 ± 2 76 ± 3
Heart rate (bpm) 71 ± 3 74 ± 2 66 ± 3
Cholesterol 
Total (mg/dL) 214 ± 7 201 ± 12 210 ± 10
LDL (mg/dL) 125 ± 9 117 ± 10 120 ± 9
VLDL (mg/dL) 19 ± 3 19 ± 2 18 ± 2
HDL (mg/dL) 70 ± 6 64 ± 4 71 ± 6
Triglyceride (mg/dL) 94 ± 14 97 ± 10 93 ± 8
Glucose (mg/dL) 93 ± 2 88 ± 3 92 ± 2
WBC (× 103/μL) 5.46 ± 0.39 5.53 ± 0.25 5.21 ± 0.36
RBC (× 106/μL) 4.76 ± 0.17 4.45 ± 0.12 4.54 ± 0.07
Platelets (× 103/μL) 223.3 ± 12.2 245.9 ± 13.6 250.4 ± 13.6
Neutrophils (%) 55.3 ± 2.7 55.9 ± 2.9 50.5 ± 4.7
Lymphocytes (%) 34.6 ± 2.5 34.9 ± 2.9 29.8 ± 3.2
Smoking history (n)
Nonsmokers 11 11 13
Ex-smokers 2 5 0
Current smokers 0 0 0
Medications (n)
Statin 2 1 0
β-Adrenergic receptor blockers 0 0 0
ACE inhibitors 3 2 0
Antidepressant 1 2 0
NSAIDs 0 0 0
HRT 1 2 1
Data are mean ± SEM. Age, BMI, medication usage, blood pressure, blood cell counts, serum glucose, and lipids were 
not significantly different among the groups (ANOVA, p > 0.05). Abbreviations: ACE inhibitors, angiotensin-converting 
enzyme inhibitors; HDL, high-density lipoprotein; HRT, hormone replacement therapy; LDL, low-density lipoprotein; 
NSAIDs, nonsteroidal anti-inflammatory drugs; RBC, red blood cells; VLDL, very low density lipoprotein; WBC, white 
blood cells. 
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FMD was significantly lower immediately 
after CAP exposure in the naive group 
(–19.4% average decrease relative to baseline 
per 100-μg/m3 increase in CAP concentra-
tion; 95% CI: –36.4%, –2.3%; p = 0.03) 
and also in the FO group (–13.7%; 95% CI: 
–24.5%, –2.9%; p = 0.01) (Table 2 and 
Figure 1). In the OO group, however, 
exposure to CAP resulted in a smaller 
nonsignifi cant decrease in FMD (–7.6%; 
95% CI: –21.5%, 6.3%; p = 0.27). In the 
FO group, FMD 20 hr after CAP exposure 
was still significantly lower than baseline 
(–21.5%; 95% CI:  –37.3%, –5.6%; 
p = 0.01). Differences between the groups 
were not significant. Reduction in FMD was 
persistent after adjusting for confounding by 
sex as well as in the “female-only” analysis 
(see Supplemental Material, Table S3). 
There was also no significant difference in 
BAD either immediately after or 20 hr after 
CAP exposure in any of the groups (Figure 1 
and Table 2).
Blood pressure. There was no significant 
difference in BP before filtered-air exposure 
between the OO, FO, and naive groups 
(Table 1). There were statistically nonsignifi-
cant increases in systolic BP 30 min after CAP 
exposure in the naive group (+2.5 mmHg 
per 100-μg/m3 increase in CAP concentra-
tion compared with filtered-air exposure; 
p = 0.09) and 60 min after exposure in 
the FO (+2.7 mmHg; p = 0.06) and OO 
(+2.1 mmHg; p = 0.22) groups. Diastolic 
BP was significantly increased 30 min after 
exposure in the naive group (+2.1 mmHg 
per 100-μg/m3 increase in CAP concentra-
tion compared with filtered-air exposure; 
p = 0.04) and 60 min after exposure in 
the FO (+2.1 mmHg; p = 0.008) and OO 
(+2.1 mmHg per 100-μg/m3 increase in CAP 
concentration compared with filtered-air 
exposure; p = 0.03) groups.
Blood markers of fibrinolysis. The average 
concentrations of blood markers of fibrino-
lysis at baseline, immediately post exposure, 
and 20 hr post exposure are presented in 
Supplemental Material, Table S4. In all three 
supplement groups, we observed higher levels 
of plasma PAI-1 in the morning (0800–0900 
hours) and lower levels in the afternoon 
(1300–1400 hours). The observed variation 
is consistent with previous reports (Paschos 
and FitzGerald 2010; Rudnicka et al. 2007) 
and may indicate diurnal variation in levels 
of plasma PAI-1; however, this study was not 
designed to further examine this hypothesis. 
the baseline tPA concentration (i.e., before 
filtered-air exposure) was significantly lower 
in the OO group compared with the naive 
group, and baseline PAI-1 and plasminogen 
concentrations were significantly lower in the 
OO and FO groups compared with the naive 
group (see Supplemental Material, Table S4), 
possibly due to effects of OO and FO supple-
mentation (Mehta et al. 1988; Pérez-Jiménez 
et al. 2006).
In the OO group, the average plasma 
concentration of tPA increased immedi-
ately after CAP exposure in the OO group 
(11.6%; 95% CI: 0.8%, 22.2%; p = 0.04), 
and this increase persisted for 20 hr, at which 
time there was a 10.9% increase (95% CI: 
0.1%, 21.8%; p = 0.05) for this group 
(Table 2 and Figure 2). In addition, plasma 
D-dimer levels were 11.6% lower (95% CI: 
Table 2. Mean percent point difference per 100-μg/m3 increase in CAP concentration relative to baseline (before filtered-air exposure) measured immediately 
after (post) and 20 hr after (FU) CAP exposure in each group.
End point
OO (n = 13) FO (n = 16) Naive (n = 13)
Post-CAP Follow-up Post-CAP Follow-up Post-CAP Follow-up
BAU
FMD –7.6 (–21.5, 6.3) –5.4 (–25.8, 15.1) –13.7 (–24.5, –2.9)* –21.5 (–37.3, –5.6)* –19.4 (–36.4, –2.3)* –17.9 (–43.0, 7.2)
BAD 0.2 (–0.5, 0.9) –0.3 (–1.4, 0.8) 0.2 (–0.3, 0.8) –0.2 (–1.0, 0.7) –0.4 (–1.3, 0.4) 0.8 (–0.5, 2.2)
Blood markers
ET-1 –4.7 (–14.8, 5.4) –10.0 (–22.1, 2.1) –0.4 (–7.8, 7.0) 1.4 (–7.9, 10.8) 8.3 (–3.7, 20.2) 17.1 (2.2, 32.0)*
tPA 11.6 (0.8, 22.2)* 10.9 (0.1, 21.8)* 2.2 (–6.4, 10.9) 1.9 (–7.2, 11.1) –0.50 (–12.8, 11.7) 1.2 (–11.7, 14.0)
PAI-1 0.1 (–6.6, 6.8) –4.4 (–15.5, 6.6) –0.6 (–5.6, 4.4) –2.3 (–10.9, 6.3) 6.3 (–1.7, 14.4) 6.2 (–7.4, 19.7)
D-dimer –4.1 (–24.0, 15.8) –11.6 (–22.6, –0.5)* –1.9 (–16.5, 12.6) 1.4 (–7.2, 10.0) –16.9 (–40.4, 6.7) –2.9 (–16.5, 10.6)
Plasminogen –6.7 (–16.3, 2.9) –5.3 (–14.3, 3.6) –3.1 (–10.4, 4.2) 1.2 (–5.7, 8.2) –2.0 (–13.6, 9.6) –3.7 (–14.6, 7.3)
vWF 4.5 (–2.5, 11.7) 0.4 (–20.7, 21.5) 0.3 (–4.9, 5.5) 7.0 (–9.4, 23.4) –0.1 (–8.5, 8.3) –0.6 (–26.5, 25.2)
Fibrinogen 1.0 (–3.8, 5.8) 0.4 (–4.0, 4.8) 0.2 (–3.4, 3.8) 2.7 (–0.7, 6.2) 5.0 (–0.8, 10.8) 2.3 (–3.1, 7.8)
CRP 0.7 (–24.4, 25.9) 3.7 (–14.4, 21.8) –1.7 (–20.7, 17.2) –5.0 (–19.1, 9.1) –2.5 (–32.8, 27.7) 9.5 (–12.7, 31.7)
ICAM-1 0.8 (–29.1, 30.7) –0.5 (–17.4, 16.3) –1.8 (–24.3, 20.6) –1.7 (–14.8, 11.3) 0.3 (–35.6, 36.3) 7.3 (–13.3, 27.9)
VCAM-1 0.1 (–28.4, 28.7) –0.7 (–20.0, 18.6) –2.4 (–23.9, 19.0) –3.2 (–18.2, 11.8) 2.1 (–32.1, 36.5) 5.5 (–18.1, 29.2)
IL-6 –1.4 (–12.3, 9.3) –1.0 (–12.3, 10.2) –3.9 (–12.2, 4.3) –1.7 (–10.5, 7.0) –4.7 (–17.7, 8.4) –9.2 (–23.0, 4.6)
IL-8 –1.1 (–5.7, 3.4) 1.2 (–4.0, 6.5) –0.1 (–3.6, 3.4) 0.3 (–3.8, 4.4) 3.7 (–1.8, 9.2) –3.3 (–9.8, 3.1)
TNFα 1.8 (–1.5, 5.2) 0.2 (–3.5, 4.0) –0.04 (–2.6, 2.5) 0.6 (–2.3, 3.5) –0.3 (–4.3, 3.7) –3.9 (–8.6, 0.6)
End points are summarized as mean and 95% confidence interval. Abbreviations: BAD, baseline diameter of brachial artery; BAU, brachial artery ultrasound; CAP, concentrated ambient air 
pollution particles; CRP, c-reactive protein; ET-1, endothelin-1; FMD, flow-mediated dilation; FO, fish oil group; ICAM-1, intercellular adhesion molecule 1; Il, interleukin; OO, olive oil group; 
PAI-1, plasminogen activator inhibitor-1; TNFα, tumor necrosis factor α; tPA, tissue-type plasminogen activator; VCAM-1, vascular cell adhesion protein 1; vWF, von Willebrand factor. 
*p < 0.05, compared with pre-CAP. 
Figure 1. Effect of concentrated ambient particle (CAP) exposure on parameters of brachial artery 
ultrasound. Flow-mediated dilation (FMD; A) and baseline diameter (BAD; B) of the brachial artery were 
measured by ultrasound before, immediately after exposure to filtered-air and CAP (post), and again the 
next morning (follow-up) as described in “Methods.” Symbols represent differences between CAP and 
filtered-air exposure, expressed as average percent point differences per 100-μg/m3 increase in CAP, 
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–22.6%, –0.5%; p = 0.04) 20 hr after CAP 
exposure in the OO group.
The association between CAP exposure 
and tPA in the OO group was robust to 
adjustment for confounding by sex, but 
changed from positive to slightly negative 
when the four men in the OO group were 
excluded from the analysis, suggesting 
substantial differences in association between 
CAP and tPA among males and females in 
the OO group (see Supplemental Material, 
Table S3). The association between CAP and 
D-dimer levels in the OO group was similar 
after adjusting for sex and after excluding 
men from the analysis (see Supplemental 
Material, Table S3). When five participants 
taking either statins or ACE inhibitors 
were excluded from the OO group, plasma 
D-dimer levels were no longer significantly 
decreased 20 hr after CAP exposure (–0.7% 
per 100-μg/m3 increase in CAP; 95% CI: 
–10.4%, 9%; p = 0.88). This suggests that 
these medications may have influenced effects 
of CAP on plasma D-dimer levels, although 
differences due to chance cannot be ruled 
out because of small sample size and poten-
tial for selection bias. Excluding participants 
using these medications did not have obvious 
impact on other associations in the OO 
group, nor did it appear to influence associa-
tions in FO or naive groups.
Endothelin‑1 level. Blood concentrations 
of endothelin-1, a potent vasoconstrictor, 
could mediate the vascular effects of CAP 
exposure. There was an increase in plasma 
endothelin-1 levels in the naive group 
(17.1%; 95% CI: 2.2%, 32.0%; p = 0.02) 
20 hr after CAP exposure, but not in the OO 
group (Figure 3 and Table 2).
Markers  of  inf lammation .  Before 
exposure to filtered air, levels of IL-8, 
ICAM-1, and VCAM-1 were significantly 
lower in the OO and FO groups relative to 
the naive group, whereas TNFα levels were 
higher in the OO and FO groups relative to 
the naive group (see Supplemental Material, 
Table S4). There were no significant changes 
in concentrations of plasma markers of 
inflammation after CAP exposure in the OO, 
FO, and naive groups (Table 2).
Discussion
In the present study, acute exposure to CAP 
was associated with decreased endothelial 
function, as measured by FMD, in middle-
aged volunteers who did not receive a dietary 
supplement. We further show that dietary 
supplementation with OO, but not FO, 
appeared to blunt the endothelial dysfunc-
tion induced by exposure to CAP. We also 
observed that the concentrations of the blood 
fibrinolysis marker tPA increased immediately 
after CAP exposure in participants supple-
mented with OO, an effect that persisted 
for 20 hr after exposure. In addition, plasma 
endothelin-1 levels were increased 20 hr after 
CAP exposure in the unsupplemented group 
but not in the OO group. Taken together, 
these findings suggest that supplementa-
tion with OO provides potentially benefi-
cial vascular effects by conferring protection 
against CAP-induced endothelial dysfunction 
in middle-aged adults. 
Endothelial dysfunction is an important 
factor in the development of hyper tension 
and athero sclerosis that is associated with 
an increased risk of coronary heart disease. 
Specifically, endothelial dysfunction induced 
by air pollution exposure has been implicated 
as an important mechanism in the develop-
ment of cardio vascular diseases (Brook et al. 
2010; Krishnan et al. 2013). Mechanistically, 
oxidative stress and inflammation are two 
mechanisms that have been associated with 
the adverse health effects of air pollution 
exposure. It has been suggested that anti-
oxidant components in certain food groups 
can limit oxidative damage and thereby 
protect endothelial function (Moreno and 
Mitjavila 2003). The results presented here 
suggest that dietary supplementation with 
OO may prevent deleterious effects of CAP 
exposure on vascular function and might, 
therefore, represent a practical approach to 
reduce the mortality and morbidity of cardio-
vascular diseases associated with PM exposure.
There was a smaller CAP-induced reduc-
tion in FMD in participants supplemented 
with OO compared with FO-supplemented 
and unsupplemented participants in this 
study, supporting a role for OO in protecting 
vascular function from PM-induced health 
effects. The oleic acid in OO has antioxidant 
and anti-inflammatory properties (Perona 
et al. 2006), and OO supplementation has 
been shown to improve endothelial function 
and lipid profile (Zern and Fernandez 2005) 
and lower the risk of coronary heart disease 
events (Estruch et al. 2013; Hertog et al. 
1995). Two months of dietary supplementa-
tion with OO was previously associated with 
improved endothelial function and a decrease 
in BP in a study of young women with mild 
hypertension (Moreno-Luna et al. 2012). 
Furthermore, in a clinical trial in healthy 
young adults, 16 weeks of supplementa-
tion with 4 g/day of OO led to an increase 
in FMD (Singhal et al. 2013). Our finding 
suggests that 4 weeks of dietary OO supple-
mentation attenuate PM-induced reductions 
in FMD, possibly due to the effect of OO 
to protect against the adverse effects of PM 
exposure on endothelial function. 
Figure 2. Effect of concentrated ambient particle (CAP) exposure on plasma markers of fibrinolysis. 
Blood was collected before and immediately after exposure (post) to filtered air and CAP, and again the 
next morning (follow-up), and markers of fibrinolysis, tPA (A) and D-dimer (B), were assayed by ELISA 
as described in “Methods.” Symbols represent differences between CAP and filtered-air exposure, 
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Figure 3. Effect of concentrated ambient particle 
(CAP) exposure on plasma endothelin-1 levels. 
Blood was collected before and immediately after 
exposure (post) to filtered air and CAP, and again 
the next morning (follow-up) and assayed for 
endothelin-1 by ELISA as described in “Methods.” 
Symbols represent differences between CAP 
and filtered-air exposure, expressed as average 
percent point differences per 100-μg/m3 increase in 
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We also observed in this study that, on 
average, participants in the OO supple-
mentation group had significant changes in 
the levels of tPA to CAP exposure, whereas 
those in FA and naive groups did not. There 
was a significant increase in plasma levels of 
tPA immediately after CAP exposure, and 
this effect persisted 20 hr post exposure in 
the OO group. tPA is a serine protease that 
catalyzes the conversion of plasminogen to 
plasmin, the major enzyme responsible for the 
breakdown of thrombi. In contrast to tPA, 
D-dimer was significantly reduced 20 hr after 
CAP exposure in the OO group, although 
the effect was no longer present after eight 
participants using statins and ACE inhibitors 
were excluded from the OO group, which 
suggests that the association may have 
been influenced by medication use in these 
participants. D-dimer is a fibrin degradation 
product present in the blood after a thrombus 
is degraded by fibrinolysis. We have previ-
ously reported that the levels of D-dimer were 
increased following controlled exposure of 
young healthy volunteers to ultrafine CAP 
(Samet et al. 2009). The increase in tPA 
level suggests that the supplementation with 
OO may activate the fibrinolysis system that 
protects against thrombosis induced by CAP 
exposure. However, it is difficult to recon-
cile this mechanism with the simultaneous 
decrease in D-dimer level observed in these 
participants. One possibility is that OO could 
be decreasing prothrombotic factors that were 
not measured in this study.
In addition, we observed that plasma levels 
of endothelin-1 were increased after CAP 
exposure in the unsupplemented group but 
not in participants supplemented with OO 
or FO. Several studies have shown increased 
plasma endothelin-1 levels after controlled 
exposure of human volunteers to diesel 
exhaust (Peretz et al. 2008) and following 
exposure to urban ambient levels of air pollu-
tion in adults (Liu et al. 2009) and children 
(Calderón-Garcidueñas et al. 2007), suggesting 
that increased concentrations of this potent 
vasoconstrictor is a consequence of endothelial 
damage resulting from air pollution exposure. 
The attenuation of CAP-induced endothelin-1 
levels in the OO group shown in this study 
suggests beneficial effects of OO supplementa-
tion on vascular tone and endothelial function. 
However, increases in BP following CAP 
exposure were comparable among the OO, 
FO, and unsupplemented groups. It has been 
suggested that the CAP-induced BP eleva-
tion may be caused by autonomic imbalance 
(Brook et al. 2009). We previously demon-
strated that CAP exposure alters the sympatho-
vagal balance (Samet et al. 2009; Tong et al. 
2012) by increasing the sympathetic input to 
the cardio vascular system, which could result 
in increased BP.
It has been hypothesized that FO-mediated 
enhancement of endothelial function is a 
potential strategy by which the population can 
be protected from the adverse effects of PM. 
Previous studies have demonstrated that FO 
(EPA and DHA) improve systemic arterial 
compliance in individuals with dyslipidemia 
(Nestel et al. 2002) and improve endothelial 
function in individuals with dyslipidemia, 
heart failure, and diabetes (Duda et al. 2009b; 
Saravanan et al. 2010). However, trials of 
FO supplementation in healthy volunteers 
have shown inconsistent results (Khan et al. 
2003; Singhal et al. 2013). One study found 
that 8 months of FO supplements improved 
endothelial function in middle-aged men 
and women (Khan et al. 2003). By contrast, 
16 weeks of DHA supplementation had no 
effect on indices of endothelial function in a 
study of healthy young volunteers (Singhal 
et al. 2013). In general, studies have shown 
that EPA and DHA levels in blood are not 
linked to FMD in normal healthy adults 
(Egert and Stehle 2011; Leeson et al. 2002; 
Sanders et al. 2011; Saravanan et al. 2010; 
Singhal et al. 2013). Consistent with these 
reports, in the present study we did not 
observe a significant benefit of 4 weeks of 
FO supplementation on CAP-induced 
reduction in FMD.
The mechanism by which OO supple-
mentation attenuates CAP-induced vascular 
effects was not investigated in this study. It is 
possible that OO supplementation increases 
the bioavailability of plasma nitrites/nitrates, 
which in turn improves endothelial function 
(Moreno-Luna et al. 2012). In the present 
study, OO supplementation appeared to 
blunt the CAP-induced reduction in FMD, 
consistent with an effect of OO on the 
bioavailability of NO. Another function of 
OO is to promote anti-inflammatory effects 
in the vasculature. It has been shown that 
oleic acid, a principal bioactive component 
of OO, inhibits endothelial activation by 
suppressing inflammatory responses in vitro 
(Carluccio et al. 1999). It is also possible 
that OO supplementation increases resis-
tance of HDL (high-density lipoprotein) and 
LDL (low-density lipoprotein) to oxidation 
(Moreno et al. 2003; Solà et al. 1997) 
induced by CAP exposure.
In order to avoid potential variations in 
FA equilibrium times and particle washout 
periods, this study did not use a standard 
crossover design involving a randomized 
exposure to air and CAP. In addition, conclu-
sions derived from the small number of 
participants included in the study may not 
be applicable to the population as a whole. 
Furthermore, the modest sample size and the 
number of secondary end points measured, 
which could inflate the significance of the 
findings, are additional statistical limitations. 
In spite of these limitations, as the first 
controlled exposure study of this type, the 
present study reports statistically significant 
differences between the response to CAPs and 
filtered air under each of the three dietary 
regimens for several important outcomes. 
These findings provide the basis for a future 
cohort study focusing on between-group 
comparisons in order to confirm and further 
evaluate OO supplementation as a protective 
intervention against the adverse health effects 
of PM inhalation.
Conclusion
In this study we observed that a 2-hr exposure 
to CAP impaired vascular endothelial function 
for up to 20 hr, and that dietary supplementa-
tion with OO, but not FO, attenuated the 
FMD reduction induced by CAP exposure. 
Further, supplementation with OO seemed 
to alter blood markers associated with fibrino-
lysis and vaso constriction in PM-exposed 
human volunteers. These data, therefore, 
suggest that OO supplementation should be 
further examined as a possible intervention to 
protect against the adverse vascular effects of 
air pollution exposure.
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